BPC-157 vs CJC-1295
A comprehensive, data-driven comparison of BPC-157 (Body Protection Compound-157) and CJC-1295 (Modified GRF 1-29). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | BPC-157 Body Protection Compound-157, PL 14736 | CJC-1295 Modified GRF 1-29, DAC:GRF |
|---|---|---|
| FDA Status | Category 2 (pending reclassification) | Category 2 (pending reclassification) |
| Category | Recovery & Healing | Growth Hormone |
| Primary Use | Tissue healing and injury recovery | Growth hormone optimization and anti-aging |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $50 - $120/mo | $35 - $70/mo |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Typical Dose | 250-500mcg daily | 1-2mg twice weekly (with DAC) |
| Frequency | Daily | Twice weekly |
| Mechanism | Synthetic peptide derived from gastric juice protein that promotes angiogenesis, modulates growth factors, and accelerates tissue repair | Growth hormone releasing hormone (GHRH) analog that stimulates pituitary gland to produce more growth hormone |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Low | Emerging |
| Clinical Trial Phase | N/A | N/A |
Key Differences
- 1CJC-1295 is generally more affordable ($35 - $70/mo) compared to BPC-157 ($50 - $120/mo).
- 2BPC-157 is dosed daily, while CJC-1295 is twice weekly.
- 3BPC-157 has low-quality evidence, while CJC-1295 has emerging-quality evidence.
- 4They belong to different categories: BPC-157 (Recovery & Healing) vs CJC-1295 (Growth Hormone).
Which Is Better For...
CJC-1295
More budget-friendly option with lower monthly costs
CJC-1295
More convenient dosing schedule (twice weekly)
BPC-157
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| BPC-157 | $50 - $120/mo | Category 2 (pending reclassification) | Various research labs |
| CJC-1295 | $35 - $70/mo | Category 2 (pending reclassification) | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
BPC-157 works via Synthetic peptide derived from gastric juice protein that promotes angiogenesis, modulates growth. CJC-1295 works via Growth hormone releasing hormone (GHRH) analog that stimulates pituitary gland to produce. They differ in FDA approval status, efficacy data, and cost.
BPC-157 typically costs $50 - $120/mo, while CJC-1295 costs $35 - $70/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
BPC-157 is not FDA-approved (Category 2 (pending reclassification)). CJC-1295 is not FDA-approved (Category 2 (pending reclassification)). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of BPC-157 include Injection site discomfort, Mild headache, Dizziness. Common side effects of CJC-1295 include Injection site reactions, Water retention, Numbness or tingling. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
BPC-157 is a synthetic peptide consisting of 15 amino acids derived from a protective protein found in human gastric juice. Although not FDA-approved, it has gained significant attention in research a...
View Full BPC-157 GuideCJC-1295 is a synthetic analog of growth hormone releasing hormone (GHRH) that stimulates the pituitary gland to release growth hormone. It exists in two forms: with DAC (Drug Affinity Complex) for ex...
View Full CJC-1295 GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between BPC-157 and CJC-1295 should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.